Literature DB >> 7437519

Evidence for both oxygen and non-oxygen dependent mechanisms of antibody sensitized target cell lysis by human monocytes.

D K Klassen, A L Sagone.   

Abstract

Recent studies suggest that the generation of reactive oxygen species (ROS) such as hydrogen peroxide (H2O2) or superoxide (O2-) may play a role in monocyte antibody-dependent cytotoxicity (ADCC). We studied ADCC by normal human monocytes, and monocytes from chronic granulomatous disease (CGD) patients, cells unable to generate ROS, toward anti-D sensitized human red cells (RBC) and an antibody sensitized lymphoblastoid cell line (CEM) by 51Cr release. The effects of hypoxia, scavengers of ROS, and the activity of the hexose monophosphate shunt pathway (HMPS) were examined. We found that monocyte HMPS activity increased two to threefold during ADCC toward RBC but was unchanged during ADCC toward CEM cells. Hypoxia decreased lysis of RBC targets by 80% but did not affect lysis of CEM cells even though hypoxia markedly decreased monocyte HMPS activity. Monocytes from CGD patients had impaired lysis of RBC but lysed CEM cells normally. We could not, however, demonstrate protection by scavengers of ROS. We conclude that monocyte ADCC involves two independent mechanisms: a nonoxidative mechanism active in the lysis of CEM cells, and an oxidative mechanism that may involve an unidentified ROS activated during ADCC toward RBC. The activation and possible interaction of these two mechanisms is determined by the nature of the target cell and sensitizing antibody.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437519

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.

Authors:  S J Rüegg; T W Jungi
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

2.  Inability of tumour cells to elicit the respiratory burst in cytotoxic, activated macrophages.

Authors:  S M Bryant; H R Hill
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

3.  Effect of oxygen radical scavengers on K-cell cytolysis.

Authors:  B U Bowman; H A Shoeb
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

4.  The role of reactive oxygen intermediates in nonspecific monocyte cytotoxicity induced by immune complexes.

Authors:  J R Geffner; M Giordano; G Serebrinsky; M Isturiz
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

5.  Effect of diethyldithiocarbamate (DDC) on human monocyte function and metabolism.

Authors:  P Conkling; D G Cornwell; A L Sagone
Journal:  Inflammation       Date:  1985-06       Impact factor: 4.092

6.  Activation of monocyte and granulocyte antibody-dependent cytotoxicity by phorbol myristate acetate.

Authors:  D K Klassen; P R Conkling; A L Sagone
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

7.  Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.

Authors:  S Kohl; D B Drath; L S Loo
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Oxygen dependence of human alveolar macrophage-mediated antibody-dependent cytotoxicity.

Authors:  P Conkling; G Papermaster-Bender; M Whitcomb; A L Sagone
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  Measurement of chemiluminescence in freshly drawn human blood. II. Clinical application of zymosan-induced chemiluminescence.

Authors:  M Heberer; M Ernst; M Dürig; M Allgöwer; H Fischer
Journal:  Klin Wochenschr       Date:  1982-12-01

10.  Phorbol myristate acetate-induced modulation of antibody-dependent cellular cytotoxicity by human polymorphonuclear leukocytes.

Authors:  Y Ichinose; K Yagawa; M Kaku; N Hara; M Ohta
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.